Skip to content
Open access

The PCSK6-CORIN Polygenic Risk Score and Ischemic Stroke: The Dose-Response Association and Partial Mediation by Hypertension.

Aug 2026 · Journal of atherosclerosis and thrombosis · 0 citations · 19 references
Medicine

TL;DR

Genetic variants in the PCSK6‑CORIN pathway are associated with IS risk, and the genetic risk may be partially mediated by hypertension.

Abstract

Aim

This study aimed to assess the association of single nucleotide polymorphisms (SNPs) in the PCSK6‑CORIN pathway with IS, the predictive ability of weighted genetic risk score (wGRS), and the mediating role of hypertension.

Methods

A total of 2,207 patients with IS and 2,590 community controls were included in this case-control study. The wGRS was developed using data from six TagSNPs in PCSK6 and CORIN. The associations, dose-response relationships, and mediation effects were assessed using logistic regression, restricted cubic spline, and mediation analyses.

Results

Two SNPs (rs1135911 and rs4695253) were significantly associated with IS under the additive model: rs1135911 (OR=1.310, P_Bonferroni=1.28×10-4) and rs4695253 (OR = 1.459, P_Bonferroni=3.17 × 10-7). Negative multiplicative interactions were observed between rs3749585 and rs4695253/rs11934749 (OR = 0.625 and 0.548, respectively; both P<0.001). The wGRS showed a linear dose-response relationship with IS (overall P<0.001, nonlinear P = 0.907). Among the wGRS quartiles, the highest quartile had an OR of 1.653 and a P-value of 3.84×10-7). The plasma CORIN levels were significantly lower in patients with IS than in the controls (973.60±589.37 pg/mL vs. 1197.85±848.46 pg/mL, P = 0.043) in 88 IS and 88 controls. A history of hypertension appeared to partially mediate the effect of wGRS on IS, with a mediation proportion of 9.4% (95% CI: 5.0%-15.7%).

Conclusions

Genetic variants in the PCSK6‑CORIN pathway are associated with IS risk, and the genetic risk may be partially mediated by hypertension.

Read PDF

Similar papers

Open access Jul 2026

Exploration of the causal relationship between inflammatory cytokines and type 2 diabetes via mendelian randomization and polygenic score

This study identified nine inflammatory cytokines with potential causal associations with T2D in European populations and in a Mongolian cohort, a PGS for genetically predicted cytokine levels showed a modest yet independent association with T2D risk after controlling for population stratification.

Cong Zhang, Yan-Ping Zhao, Hui Pang et al. · 0 citations
Open access Jul 2026

Examining the potential causal relationships among smoking, blood DNA methylation, and type 2 diabetes development: A Mendelian randomization study

Genomic analysis presented convincing evidence supporting the association between genetically predicted smoking initiation and an increased susceptibility to type 2 diabetes, highlighting the role of epigenetic DNA methylation.

Wenhua Li, Yixiao Li, Pan Dong et al. · 0 citations
Open access Aug 2026

LPA genetic variation is associated with type 2 diabetes after adjustment for lipoprotein(a) concentration: results of the Aragon Workers’ health study

The findings suggest that common LPA variation represented by the 15-SNV genetic score may contribute to T2D risk through mechanisms not fully captured by circulating Lp(a) concentration alone.

P. Corredoira, Daniel Bello Álvarez, Itziar Lamiquiz Moneo et al. · 0 citations
Open access Aug 2026

Polygenic risk scores predict blood pressure changes independent of dietary intervention: a secondary analysis of the NUPRESS trial

This study aimed to investigate whether genetic variability, assessed through polygenic risk scores (PRSs), predicts blood pressure (BP) changes in individuals with systemic arterial hypertension (SAH), and to explore potential interactions between genetic risk and dietary interventions. This study represents a seconda...

L. C. Holzbach, Aline Marcadenti, Â. Bersch-Ferreira et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.